Insights Into Renal Cell Carcinoma (RCC)

Perspectives of community physicians on the treatment of advanced renal cell carcinoma (RCC), recently introduced and upcoming agents

Pacific Northwest January 14, 2021

Faculty Chair

Neeraj Agarwal, MD

Huntsman Cancer Institute, Salt Lake City, UT

Northwest January 21, 2021

Faculty Chair

Sumanta Pal, MD

City of Hope Comprehensive Cancer Center, Duarte, CA

Southeast May 5, 2021

Faculty Chair

Tian Zhang, MD

Duke Cancer Center, Durham, NC

TX/West June 9, 2021

Faculty Chair

Rana McKay, MD

UC San Diego Medical Center, San Diego, CA

TN June 28, 2021

Faculty Chair

Tian Zhang, MD

Duke Cancer Center, Durham, NC

Northeast July 21, 2021

Faculty Chair

Tian Zhang, MD

Duke Cancer Center, Durham, NC

West August 26, 2021

Faculty Chair

Sumanta Pal, MD

City of Hope Comprehensive Cancer Center, Duarte, CA

Midwest/Central August 31, 2021

Faculty Chair

Ulka Vaishampayan, MD

Karmanos Cancer Center, Detroit, MI

National September 21, 2021

Faculty Chair

Sumanta Pal, MD

City of Hope Comprehensive Cancer Center, Duarte, CA

Mid-Atlantic October 5, 2021

Faculty Chair

Tanios Bekaii-Saab, MD

Mayo Clinic Cancer Center, Phoenix, AZ

NY, MD, VA October 27, 2021

Faculty Chair

Bradley McGregor, MD

Dana-Farber Cancer Institute, Boston, MA

More Information

  • Virtual Series
  • Washington, Oregon, Idaho

More Information

  • Virtual Series
  • California, Nevada

More Information

  • Virtual Series
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia

More Information

  • Virtual Series
  • Texas, Arizona, California

More Information

  • Virtual Series
  • Tennessee

More Information

  • Virtual Series
  • New York, New Jersey, Connecticut

More Information

  • Virtual Series
  • California, Arizona, Hawaii, Nevada

More Information

  • Virtual Series
  • Illinois, Iowa, Nebraska, North Dakota, South Dakota, Minnesota, Wisconsin, Michigan, Indiana, Ohio
  • Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana

More Information

  • Virtual Series
  • National

MORE INFORMATION

  • Virtual Series
  • Georgia, Florida

MORE INFORMATION

  • Virtual Series
  • New York, Maryland, Virginia

Example Agenda

Export meeting topics

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of renal cell carcinoma
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies will be obtained: sunitinib, pazopanib, cabozantinib, axitinib, lenvatinib, ipilimumab, pembrolizumab, nivolumab, avelumab, everolimus, and combinations of these drugs

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors will comprise 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.